Cargando…
β‐Blockade attenuates renal blood flow in experimental endotoxic shock by reducing perfusion pressure
Clinical data suggests that heart rate (HR) control with selective β1‐blockers may improve cardiac function during septic shock. However, it seems counterintuitive to start β‐blocker infusion in a shock state when organ blood flow is already low or insufficient. Therefore, we studied the effects of...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900489/ https://www.ncbi.nlm.nih.gov/pubmed/31814327 http://dx.doi.org/10.14814/phy2.14301 |
_version_ | 1783477363561988096 |
---|---|
author | van Loon, Lex M. Rongen, Gerard A. van der Hoeven, Johannes G. Veltink, Peter H. Lemson, Joris |
author_facet | van Loon, Lex M. Rongen, Gerard A. van der Hoeven, Johannes G. Veltink, Peter H. Lemson, Joris |
author_sort | van Loon, Lex M. |
collection | PubMed |
description | Clinical data suggests that heart rate (HR) control with selective β1‐blockers may improve cardiac function during septic shock. However, it seems counterintuitive to start β‐blocker infusion in a shock state when organ blood flow is already low or insufficient. Therefore, we studied the effects of HR control with esmolol, an ultrashort‐ acting β1‐selective adrenoceptor antagonist, on renal blood flow (RBF) and renal autoregulation during early septic shock. In 10 healthy sheep, sepsis was induced by continuous i.v. administration of lipopolysaccharide, while maintained under anesthesia and mechanically ventilated. After successful resuscitation of the septic shock with fluids and vasoactive drugs, esmolol was infused to reduce HR with 30% and was stopped 30‐min after reaching this target. Arterial and venous pressures, and RBF were recorded continuously. Renal autoregulation was evaluated by the response in RBF to renal perfusion pressure (RPP) in both the time domain and frequency domain. During septic shock, β‐blockade with esmolol significantly increased the pressure dependency of RBF to RPP. Stopping esmolol showed the reversibility of the impaired renal autoregulation. Showing that clinical diligence and caution are necessary when treating septic shock with esmolol in the acute phase since esmolol reduced RPP to critical values thereby significantly reducing RBF. |
format | Online Article Text |
id | pubmed-6900489 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69004892019-12-20 β‐Blockade attenuates renal blood flow in experimental endotoxic shock by reducing perfusion pressure van Loon, Lex M. Rongen, Gerard A. van der Hoeven, Johannes G. Veltink, Peter H. Lemson, Joris Physiol Rep Original Research Clinical data suggests that heart rate (HR) control with selective β1‐blockers may improve cardiac function during septic shock. However, it seems counterintuitive to start β‐blocker infusion in a shock state when organ blood flow is already low or insufficient. Therefore, we studied the effects of HR control with esmolol, an ultrashort‐ acting β1‐selective adrenoceptor antagonist, on renal blood flow (RBF) and renal autoregulation during early septic shock. In 10 healthy sheep, sepsis was induced by continuous i.v. administration of lipopolysaccharide, while maintained under anesthesia and mechanically ventilated. After successful resuscitation of the septic shock with fluids and vasoactive drugs, esmolol was infused to reduce HR with 30% and was stopped 30‐min after reaching this target. Arterial and venous pressures, and RBF were recorded continuously. Renal autoregulation was evaluated by the response in RBF to renal perfusion pressure (RPP) in both the time domain and frequency domain. During septic shock, β‐blockade with esmolol significantly increased the pressure dependency of RBF to RPP. Stopping esmolol showed the reversibility of the impaired renal autoregulation. Showing that clinical diligence and caution are necessary when treating septic shock with esmolol in the acute phase since esmolol reduced RPP to critical values thereby significantly reducing RBF. John Wiley and Sons Inc. 2019-12-09 /pmc/articles/PMC6900489/ /pubmed/31814327 http://dx.doi.org/10.14814/phy2.14301 Text en © 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of The Physiological Society and the American Physiological Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research van Loon, Lex M. Rongen, Gerard A. van der Hoeven, Johannes G. Veltink, Peter H. Lemson, Joris β‐Blockade attenuates renal blood flow in experimental endotoxic shock by reducing perfusion pressure |
title | β‐Blockade attenuates renal blood flow in experimental endotoxic shock by reducing perfusion pressure |
title_full | β‐Blockade attenuates renal blood flow in experimental endotoxic shock by reducing perfusion pressure |
title_fullStr | β‐Blockade attenuates renal blood flow in experimental endotoxic shock by reducing perfusion pressure |
title_full_unstemmed | β‐Blockade attenuates renal blood flow in experimental endotoxic shock by reducing perfusion pressure |
title_short | β‐Blockade attenuates renal blood flow in experimental endotoxic shock by reducing perfusion pressure |
title_sort | β‐blockade attenuates renal blood flow in experimental endotoxic shock by reducing perfusion pressure |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900489/ https://www.ncbi.nlm.nih.gov/pubmed/31814327 http://dx.doi.org/10.14814/phy2.14301 |
work_keys_str_mv | AT vanloonlexm bblockadeattenuatesrenalbloodflowinexperimentalendotoxicshockbyreducingperfusionpressure AT rongengerarda bblockadeattenuatesrenalbloodflowinexperimentalendotoxicshockbyreducingperfusionpressure AT vanderhoevenjohannesg bblockadeattenuatesrenalbloodflowinexperimentalendotoxicshockbyreducingperfusionpressure AT veltinkpeterh bblockadeattenuatesrenalbloodflowinexperimentalendotoxicshockbyreducingperfusionpressure AT lemsonjoris bblockadeattenuatesrenalbloodflowinexperimentalendotoxicshockbyreducingperfusionpressure |